Wani Yoji, Saegusa Makoto, Notohara Kenji
Department of Pathology, Kurashiki Central Hospital, Japan.
Histol Histopathol. 2009 Feb;24(2):149-55. doi: 10.14670/HH-24.149.
Corded and hyalinized endometrioid carcinoma (CHEC), showing spindle and/or corded (SPICO) cells often in the background of hyalinized stroma, is a rare variant of uterine endometrioid carcinomas. The aim of our study was to explore the status of cell-adhesion molecules (beta-catenin, E-cadherin) in CHECs and to survey whether immunostains for beta-catenin and p53 can help to distinguish CHECs from their morphological mimics: malignant mixed mullerian tumors (MMMTs) and uterine tumors resembling ovarian sex-cord tumors (UTROSCTs). Immunohistochemistry was performed and scored for each element as follows: 0: negative, 1+: <10% positive cells, 2+: 10-30%, 3+: >30%. The SPICO patterns were classified as spindle/fusiform; 3, corded; 1, and both; 2. SPICO components consisted of <10%: 4, 10-30%: 1, >30%: 1. Five contained squamous components. In SPICO elements of all CHECs, nuclear beta-catenin expression (score: 1+; 1, 2+; 2, 3+; 3) and complete loss of membranous expression of E-cadherin was observed. In contrast, comparable components (sarcomatous ones for eight MMMTs or sex-cord-like ones for six UTROSCTs) showed no nuclear positivity for beta-catenin. p53 expression was observed in SPICO (64.7%), sarcomatous (87.5%), and sex-cord-like (50%) components, and sarcomatous areas of most MMMTs notably showed diffuse and intense staining. Sequence analysis of PCR amplification products of exon 3 of the beta-catenin gene revealed mutation in all cases, except two lacking SPICO components represented on microdissected areas. Our results suggest that alterations in beta-catenin/E-cadherin complex play a critical role in SPICO features. Immunostain for beta-catenin and p53 is a promising approach for distinguishing CHECs from MMMTs and UTROSCTs.
条索状和玻璃样变的子宫内膜样癌(CHEC),常可见梭形和/或条索状(SPICO)细胞,且背景多为玻璃样变的间质,是子宫子宫内膜样癌的一种罕见变异型。本研究的目的是探究CHEC中细胞黏附分子(β-连环蛋白、E-钙黏蛋白)的状态,并研究β-连环蛋白和p53免疫染色能否有助于将CHEC与其形态学相似肿瘤:恶性苗勒管混合瘤(MMMT)和子宫性索样肿瘤(UTROSCT)相鉴别。进行免疫组织化学检测,并对每个指标按如下标准评分:0分:阴性;1+:阳性细胞<10%;2+:阳性细胞10% - 30%;3+:阳性细胞>30%。SPICO模式分为:梭形/纺锤形;3分,条索状;1分,两者皆有;2分。SPICO成分占比<10%:4例,10% - 30%:1例,>30%:1例。5例含有鳞状成分。在所有CHEC的SPICO成分中,均观察到β-连环蛋白核表达(评分:1+;1例,2+;2例,3+;3例)以及E-钙黏蛋白膜表达完全缺失。相比之下,类似成分(8例MMMT的肉瘤样成分或6例UTROSCT的性索样成分)β-连环蛋白无核阳性。在SPICO成分(64.7%)、肉瘤样成分(87.5%)和性索样成分(50%)中均观察到p53表达,且大多数MMMT的肉瘤样区域显著呈现弥漫性强染色。β-连环蛋白基因第3外显子PCR扩增产物的序列分析显示,除2例显微切割区域缺乏SPICO成分的病例外,其余病例均有突变。我们的结果表明,β-连环蛋白/E-钙黏蛋白复合物的改变在SPICO特征中起关键作用。β-连环蛋白和p53免疫染色是鉴别CHEC与MMMT和UTROSCT的一种有前景的方法。